ENZND
Viskase Holdings, Inc.
$5.80
+0.87%
No data for this timeframe.
Vol
SEC Reports2
Recent Activity
Apr 21, 2026
SEC
Viskase Holdings, Inc. amended its credit agreement to extend the maturity date by one year and increase interest rates,
8-K — Impact 6/10
Apr 16, 2026
SEC
Viskase Holdings, Inc. changed its independent registered public accounting firm, appointing Grant Thornton LLP as the n
8-K — Impact 3/10
Mar 26, 2026
Insider
ICAHN CARL C was granted 7,407,489 shares
10%+ Owner
Mar 25, 2026
Insider
ICAHN CARL C disposed of 39,277 shares
10%+ Owner
Mar 25, 2026
Insider
ICAHN CARL C was granted 5,658,396 shares
10%+ Owner
Latest Reports
BEARISH
8-K
6/10
Viskase Holdings, Inc. amended its credit agreement to extend the maturity date by one year and increase interest rates,
Apr 21, 2026
NEUTRAL
8-K
3/10
Viskase Holdings, Inc. changed its independent registered public accounting firm, appointing Grant Thornton LLP as the n
Apr 16, 2026
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Mar 26, 2026 | ICAHN CARL | A | $0.00 |
| Mar 25, 2026 | ICAHN CARL | D | $0.00 |
| Mar 25, 2026 | ICAHN CARL | A | $0.00 |
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
1 unique insiders with 3 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | ICAHN CARL C | 10%+ Owner | AWARD | 7,407,489 | — | — |
| Mar 25, 2026 | ICAHN CARL C | 10%+ Owner | D | 39,277 | — | — |
| Mar 25, 2026 | ICAHN CARL C | 10%+ Owner | AWARD | 5,658,396 | — | — |
2 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 1 neutral. Avg impact: 4.5/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2015-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2014-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.